HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 22, No 01, January 2018 – Weighing the options       » Scientists close in on origin of SARS       » Chinese researchers map key protein in DNA repair with near-atomic resolution       » Ryzodeg reduces hypoglycaemia in type 2 diabetic fasting patients       » United States cancer drug costs increasing despite competition       » Eating yogurt may help reduce chronic inflammation in women      
INSIDE INDUSTRY For e-subscribers (PDF)
Vol 21, No 12, December 2017
Asia-Pacific, the rising region for cancer vaccine clinical trials

North America takes the lead with the highest percentage of cancer vaccine clinical trials but Asia-Pacific is rising, especially with the Chinese government鈥檚 recent proposal on a new regulatory process for drug approvals.

Non-small cell lung cancer has largest number of clinical trials in Australia

3,199 clinical trials took place across all diseases and phases in Australia, with non-small cell lung cancer having the largest number of clinical trials, a pattern reflected globally.

Global dermatology pipeline to see shift towards increased usage of biologics

42 per cent of the pipeline is in the Preclinical stage, 14 per cent in the discovery stage and only 3 per cent of drugs in the Pre-registration stage.

FDA approves first 0.1 mg auto-injector for life-threatening allergic reactions in infants and small children

First and only epinephrine auto-injector (EAI) approved with a needle length and dose specifically designed for infants and children weighing 16.5 to 33 pounds (7.5 to 15 kilograms).

FDA approves first two-drug regimen for certain patients with HIV

The standard HIV-1 treatment for adults currently includes three or more drugs. But with the FDA-approved Juluca, only two drugs are needed. Limiting the number of drugs in the HIV treatment regimen can help reduce toxicity in patients.

New early-breast cancer drug to be made available in Australia, New Zealand and South-East Asia

Five-year follow up data shows Nerlynx reduces risk of invasive disease recurrence by 27 per cent in women with early-stage, HER2+ breast cancer

Multi-omic data analytics collaboration between the University of Oxford and Holmusk

The objective is to produce metabolic pathway models, to predict changes in metabolism in the diabetic heart.

NRGene's genomic analysis project with Monsanto advances

NRGene has integrated and delivered Monsanto鈥檚 genomic and breeding data into the GenoMAGIC platform for molecular breeding evaluations

Samsung BioLogics receives first FDA approval at world's largest plant

Prove its global quality competitiveness such as biopharmaceutical quality and manufacturing systems with the world鈥檚 largest single plant with 152,000 liters of capacity in addition to its first plant.

TLC welcomes Mayor of Leiden and delegation to Taipei headquarter

Warren Wang appointed senior vice president and president of Asia Pacific of Boston Scientific

Supratim Bose retires as executive vice president and president of AMEA.

MiRXES reveals globalisation plans for 2018 and 2019

MiRXES announced ISO certified manufacturing facility, CE-IVD cleared gastric cancer kit and launch of a new life science reagent, BlitzAmp.

QuintilesIMS is now IQVIA
Quotient Sciences launches as the new global identity for Quotient Clinical
ESMO Asia 2017 Congress
  • More care is needed for cancer supportive care
  • ALEX study shows alectinib 600 mg more effective than crizotinib in Asian lung cancer patients
  • Study analyses mutations in cerebrospinal fluid in lung cancer with brain metastases
  • Study finds all Myanmar mouth cancer patients chew betel quid
NEWS CRUNCH  
news Biology of Ageing II - Impactful Interventions
news Separation of conjoined twins presents surgical and ethical challenges for MassGeneral Hospital for Children staff
news MIT Technology Review announces 2018's 10 'Innovators Under 35 Asia'
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Addressing the ageing population / Clinical trials
March:
Nutrition / Women in Science
April:
Digestive health / Intellectual property
May:
Asthma / Dental health
June:
Oncology / Biotech landscape in APAC
July:
Water management / Vaccination
August:
Regenerative medicine / Biotech start ups
September:
Digital healthcare / 3D printing
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy